Sunrest Lifescience (NSE:SUNREST) Other Stockholders Equity: ₹161.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
42 GF Score
Price ₹35.00
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Other Stockholders Equity?

Sunrest Lifescience NSE:SUNREST 42 Other Stockholders Equity is ₹161.4 Mil as of Mar. 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 42/100. The stock has 5 warning signs investors should review.

Sunrest Lifescience's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹161.4 Mil.

Sunrest Lifescience's quarterly Other Stockholders Equity increased from Sep. 2024 (₹-0.0 Mil) to Mar. 2025 (₹1.2 Mil) and increased from Mar. 2025 (₹1.2 Mil) to Mar. 2026 (₹161.4 Mil).

Sunrest Lifescience's annual Other Stockholders Equity increased from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹1.2 Mil) and increased from Mar. 2025 (₹1.2 Mil) to Mar. 2026 (₹161.4 Mil).

Sunrest Lifescience Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Other Stockholders Equity Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 0.00 0.00 1.20 161.36

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.00 1.20 161.36
NSE:SUNREST
42GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹161.4 Mil mean?
Sunrest Lifescience (NSE:SUNREST) has a Other Stockholders Equity of ₹161.4 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sunrest Lifescience and its competitors.
Is Sunrest Lifescience's Other Stockholders Equity too high?
Sunrest Lifescience's current Other Stockholders Equity is ₹161.4 Mil. Overall, Sunrest Lifescience has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Other Stockholders Equity compare to competitors?
Sunrest Lifescience's Other Stockholders Equity of ₹161.4 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sunrest Lifescience and its competitors. Sunrest Lifescience's current Other Stockholders Equity is ₹161.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Other Stockholders Equity of ₹161.4 Mil. The current Other Stockholders Equity is ₹161.4 Mil. Sunrest Lifescience's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Other Stockholders Equity is ₹161.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
42GF Score

Get the complete analysis for NSE:SUNREST

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.00
Price